Status:
UNKNOWN
The Alterations of Metabolic Adipo-myokines and Body Composition in End Stage Lung Cancer
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Lung Cancer Metastatic
Eligibility:
All Genders
20-100 years
Brief Summary
The investigators conduct this prospective study and wish to elucidate the association of serial change of body composition, serum adipo-myokines and adverse effect of chemotherapy and lung cancer pro...
Detailed Description
Recently, the skeletal muscle was viewed as having biochemical function in additional to traditional biomechanical function. What's more important is that muscles could synthesize and release adipo-my...
Eligibility Criteria
Inclusion
- Diagnosis of lung cancer stage III to stage IV
- Adults over 20 years old
- Daily performance status of 0- 2
Exclusion
- 1\. Cardiac stents or pacemakers
Key Trial Info
Start Date :
February 2 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06060262
Start Date
February 2 2023
End Date
November 30 2025
Last Update
September 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 83301